Daniel Belletti
AstraZeneca (United Kingdom)(GB)AstraZeneca (Germany)(DE)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Health Promotion and Cardiovascular Prevention, Pharmaceutical Practices and Patient Outcomes, Antiplatelet Therapy and Cardiovascular Diseases, Multiple Sclerosis Research Studies
Most-Cited Works
- → Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey(2011)70 cited
- → A narrative review of clinical inertia: focus on hypertension(2009)65 cited
- → Correlates of hypertension control in a primary care setting(2004)54 cited
- → Identifying Barriers to Hypertension Care: Implications for Quality Improvement Initiatives(2008)54 cited
- → Review: Clinical Inertia in the Management of Chronic Obstructive Pulmonary Disease(2012)49 cited
- Cardiac cath lab activation by the emergency physician without prior consultation decreases door-to-balloon time.(2005)
- → Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States(2010)30 cited
- → Perspectives on electronic medical records adoption: electronic medical records (EMR) in outcomes research(2010)24 cited
- Hypertension treatment and control within an independent nurse practitioner setting.(2011)
- You wrote the prescription, but will it get filled?(2011)